Chemicals · Specialty Chemicals
ROIC in Specialty Chemicals
Damodaran's Jan 2026 return-on-capital spreads for specialty and basic chemicals, why large specialty groups file no ROIC, and how to build one yourself.
Selborne Research · Specialty Chemicals coverage: 7 guides, 6 company profiles, a primer and Excel model
Educational analysis for professional use. This guide is not investment advice or a recommendation to buy or sell any security, and it is not personalised.
On this page
ROIC Minus WACC Is the Value-Creation Test
A high gross margin is not enough for a specialty multiple. The business has to earn more on its capital than that capital costs, on what is already invested and on each new dollar. Specialty chemicals as an industry pass that test; basic chemicals fail it. No large specialty group files an FY2025 ROIC, so the work starts from industry figures and then builds a return for the company.
Industry Figures (Damodaran, Jan 2026)
| Metric | Specialty chemicals | Basic / commodity chemicals |
|---|---|---|
| Return on capital, after tax | 10.95% (59 firms) | 3.72% (29 firms) |
| Cost of capital (WACC) | 7.25% | 6.22% |
| ROIC − WACC spread (percentage points) | +3.70 pp | −2.50 pp |
| EBITDA margin | 18.01% | 12.34% |
Damodaran computes each figure on the summed financials of every US company in the industry, so it describes the group as a whole. Individual companies can sit anywhere, and a high margin does not guarantee a high return: the fictional lithium producer in the primer’s Excel model makes a 21.7% EBITDA margin at its long-run price yet earns a 5.4% return on capital against the 8.94% cost of capital the model sets for a lithium producer, because its plants need so much capital per dollar of sales.
Reading the Spread
| ROIC − WACC spread | What it says about the economics |
|---|---|
| > +3 pp | Returns clear the cost of capital with room to spare; the pattern a multiple above basic chemicals rests on |
| 0 to +3 pp | Returns cover the cost of capital; any premium needs company-level evidence |
| < 0 pp | Reinvestment destroys value; the pattern of basic chemicals as an industry |
The ranges are a convention, and the specialty industry’s spread sits just inside the top one. They describe a business’s economics, not a verdict on any share.
Why Company ROIC Is Missing From FY2025 Filings
| Company | What is filed instead of ROIC |
|---|---|
| Sherwin-Williams | Return on sales 10.9%; return on assets 9.9%; return on equity 63.4%; executive pay uses return on net assets employed |
| Ecolab | Organic ROIC only in the rules for executive share awards |
| PPG | No ROIC or other return-on-capital percentage |
| DuPont | ROIC > WACC listed as a test for acquisitions; no FY2025 ROIC |
| Albemarle | 2025 long-term incentive plan replaced adjusted ROIC with cost-centre expense and shareholder return |
| IFF | ROIC only in the definition of executive share awards |
A ROIC in a pay footnote is the board’s own definition, measured over an award period. Build the figure from the balance sheet and normalised operating income, or use industry figures labelled as Damodaran’s.
DuPont: a Return Test for Deals
At its September 2025 Investor Day DuPont listed ROIC above WACC among the financial criteria an acquisition must meet, beside a target of net debt below 2.0 times EBITDA. That is a screen for deals. It says nothing about what the existing business earns.
The filings cover the business left after DuPont spun off Electronics as Qnity in November 2025: organic growth of +2%, an operating EBITDA margin up to 23.8% from 22.8%, and derived net debt of about 1.5 times EBITDA. Healthcare & Water Technologies grew 7% organically while Diversified Industrials fell 2%. A growing water business and a shrinking industrial one will not earn the same on the next dollar invested, so build a return for each.
Linking Spread to Multiples
The return spread lines up with the valuation gap: Damodaran’s Jan 2026 aggregate EV/EBITDA is 13.36x for specialty chemicals against 8.57x for basic, 56% higher. The specialty vs commodity guide covers when to strip a commodity-linked segment out first; that segment needs its own return assumption.
Building a Company’s ROIC Yourself
- Where a commodity-linked segment swings, normalise EBITDA to what it would earn at an average point in the cycle (Albemarle’s gross margin was 1.2% in FY2024 and 13.0% in FY2025).
- Deduct depreciation and amortisation, then tax the operating profit at the statutory or cash rate that fits the company’s mix of countries.
- Invested capital = net working capital + net PP&E + goodwill and intangibles − excess cash, defined the same way for every company compared.
- Set the result against a WACC built from sector beta and capital structure, or against Damodaran’s industry figure for specialty chemicals.
- Read the spread against the ranges above before comparing the business with specialty or commodity multiples.
The spread tells you whether a margin is earned on a little capital or a lot. Ecolab and IFF are good places to practise: both file margin and pricing evidence but no ROIC.
Specialty Chemicals Sector Primer
A pricing-power compounder and a commodity-linked producer run through the same ten-year DCF, to show when a specialty label has earned its multiple.
- 15 sections, from pass-through and margin stability to a ten-year DCF and the ROIC test behind a premium multiple
- 40 pages
- a pricing-power coatings company and a commodity-linked lithium producer
- 2 worked archetypes
- listed specialty groups on filed organic growth, price contribution and margins
- 6-company screen
The Excel model is the primer's specialty-versus-commodity test live across 12 sheets: a pricing-power coatings archetype valued on a ten-year DCF with organic growth, a stable margin and working capital; a commodity-linked lithium archetype whose price reverts from a trough to a long-run level, valued on the same DCF with a market multiple as a cross-check; a raw-material pass-through test; a derived multiple from ROIC, growth and WACC; ROIC-versus-WACC and leverage screens; and a live sensitivity grid. Change the margin or the terminal growth rate and the value moves; change the pass-through rate and the margin a cost shock takes moves with it.
See what's in the Specialty Chemicals Sector Primer →£25 PDF · £59 with the Excel model · £159 for all three Chemicals industries
Frequently Asked Questions
- What ROIC spread supports a specialty chemicals premium?
- There is no official threshold. A common convention reads a spread of ROIC over WACC above 3 points as returns that clear the cost of capital with room to spare, the pattern a multiple above basic chemicals rests on; 0 to 3 points as returns that cover the cost of capital, where any premium needs company evidence; and a negative spread as reinvestment that destroys value. Damodaran's Jan 2026 industry figures give specialty chemicals +3.70 points (return on capital 10.95% less cost of capital 7.25%) and basic chemicals −2.50 points (3.72% less 6.22%).
- Why don't major specialty companies file ROIC in FY2025?
- None of the six large specialty groups covered here reports one. Sherwin-Williams files return on sales of 10.9%, return on assets of 9.9% and return on equity of 63.4%. Ecolab and IFF use ROIC only in executive pay rules; PPG publishes no return-on-capital figure; Albemarle dropped adjusted ROIC from its 2025 incentive plan; DuPont lists ROIC above WACC as a test for acquisitions, which is not a reported return.
- How does DuPont frame value creation without filed ROIC?
- At its September 2025 Investor Day DuPont listed ROIC above WACC among the criteria an acquisition must meet, and set a target of net debt below 2.0 times EBITDA. Neither is a reported return. FY2025 continuing operations made a 23.8% operating EBITDA margin with derived net debt of about 1.5 times EBITDA, but the 10-K gives no ROIC, so an analyst builds one or uses Damodaran's industry figures.
- How does ROIC connect to reinvestment discipline in specialty chemicals?
- Growth creates value only when new capital earns more than it costs, whatever the margin. Damodaran's Jan 2026 figures put specialty chemicals' return on capital at 10.95% against a 7.25% cost of capital. Basic chemicals earn 2.50 points below theirs, which is why reinvestment in commodity plants often destroys value unless it is well timed.
Read next
Valuing Specialty Chemicals (Premium P/E)
Why trailing P/E fails; Damodaran EV/EBITDA +56% specialty premium; forward P/E ~18-24x band; why commodity-linked earnings weaken the case for a premium.
Specialty vs Commodity Chemicals
Performance versus molecule-cost economics; S&P risk scores specialty '2' vs commodity '4'; filed margin spreads across SHW, ECL, PPG, DD, IFF and ALB.
ROCE and the Gases Oligopoly
Four filers, four definitions of return on capital (LIN 24.2%, AI 11.2%, APD 10.1%, NSHD 7.1%), and why each is read against its own cost of capital.
See it applied
These company profiles apply the concepts from this guide to real public companies.